Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

J Hadoux; A Lamarca; E Grande; D Deandreis; G Kaltsas; E T Janson; B Tombal; M Pavel; J Thariat; M F van Velthuysen; P Herman; C Dromain; E Baudin; A Berruti; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

doi:10.1016/j.esmoop.2024.103664

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1.

Authors

Affiliations

¹ Département d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France.
² Department of Oncology, OncoHealth Institute, Fundación Jiménez Díaz University Hospital, Madrid, Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, University of Manchester, Manchester, UK.
³ Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
⁴ Département d'Imagerie, Service d'Oncologie Endocrinienne, Gustave Roussy, Villejuif, France; Nuclear Medicine Service, Gustave Roussy, Villejuif, France.
⁵ First Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
⁶ Department of Medical Sciences, Endocrine Oncology Unit, Uppsala University, Uppsala, Sweden.
⁷ Institut de Recherche Clinique, Cliniques Universitaires Saint-Luc (UCLouvain Saint-Luc), Woluwe-Saint-Lambert, Belgium.
⁸ Department of Medicine 1, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany.
⁹ Department of Radiation Oncology, Baclesse Cancer Center, Caen, France.
¹⁰ Department of Pathology, Erasmus Medical Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
¹¹ Department of Otorhinolaryngology, Head and Neck Surgery, Hôpital Lariboisière AP-HP, Paris, France.
¹² Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
¹³ Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

Abstract

-
This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours.
-
Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included.
-
The guideline covers clinical imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up.
-
The authors comprise a multidisciplinary group of experts from different institutions and countries in Europe.
-
Recommendations are based on available scientific data and the authors’ collective expert opinion.

Keywords: ESMO guideline; diagnosis; intrathyroid carcinoma; management; parathyroid carcinoma; rare endocrine neoplasms.

Publication types

Practice Guideline